Medtronic Neuromodulation recalls A71200 Vanta" Clinician Programmer Application
- Recalling company
- Medtronic Neuromodulation
- Product
- A71200 Vanta" Clinician Programmer Application (CP App) version 2.0.2465 and 2.0.2683, Product number A71200. Software is deployed and operated on Samsung tablets (CFN CT900).
- Reason
- Complaints received that Vanta A71200 CP App does not function as intended during use. There is a potential for prolonged or postponed surgical procedure.
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Dec 3, 2025
- Reported
- Jan 21, 2026
- Distribution
- Worldwide - US Nationwide distribution.
- Status
- Ongoing
- Quantity
- 7123
- Lot / codes
- version 2.0.2465 and 2.0.2683 UDI-DI (GTIN) 00763000520083 Affected product is the software. Implanted Vanta Neurostimulator devices are not affected.
- Company location
- Minneapolis, MN
- Recall type
- Voluntary: Firm initiated
- Recall number
- Z-1043-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number Z-1043-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.